CD33-directed immunotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD33-directed immunotherapy, covering 2025-03-14 to 2025-03-14. Get the full timeline:
Most recent: Clinical Trial Update: Genetic Ablation of CD33 in HSC to Broaden the Therapeutic Index of CD33-directed Immunotherapy in Patients with AML [Phase 1]